Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia, improved ...
MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for ...
Medpage Today on MSN14d
Leukemia Drug Shows Promise in Dementia With Lewy BodiesOpens in a new tab or window The chronic myeloid leukemia drug nilotinib (Tasigna) improved biomarkers and cognitive outcomes ...
Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.
Patient characteristics are consistent with other DLB studies -PURCHASE, N.Y., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, ...
About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...
Analyst Sumant Kulkarni of Canaccord Genuity maintained a Buy rating on CervoMed (CRVO – Research Report), retaining the price target of ...
Attempts to discover a breakthrough dementia drug might be drawing attention these days, but traditional medicinal products ...
ComingSoon on MSN16d
The Penguin: What is Lewy Body Dementia? Francis Cobb’s Diagnosis ExplainedThe Penguin recently aired its sixth episode. The episode was filled with interesting twists and turns, leaving viewers on ...
Attempts to discover a breakthrough dementia drug might be drawing attention these days, but traditional medicinal products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback